Check-Cap Ltd.

0.3650+0.0010+0.28%Vol 329.58K1Y Perf -75.41%
May 18th, 2022 16:00 DELAYED
BID0.3551 ASK0.3650
Open0.3600 Previous Close0.3640
Pre-Market- After-Market0.36
 - -  -0.01 -1.37%
Target Price
2.00 
Analyst Rating
Strong Buy 1.00
Potential %
447.95 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★+ —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
3.92 
Earnings Rating
Neutral
Market Cap16.87M 
Earnings Date
18th May 2022
Alpha-0.02 Standard Deviation0.40
Beta0.36 

Today's Price Range

0.35510.3700

52W Range

0.30201.91

5 Year PE Ratio Range

-0.6000-1.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
10.30%
1 Month
-1.68%
3 Months
-38.10%
6 Months
-58.27%
1 Year
-75.41%
3 Years
-86.37%
5 Years
-98.46%
10 Years
-

TickerPriceChg.Chg.%
CHEK0.36500.00100.28
AAPL140.82-8.4200-5.64
GOOG2 248.02-86.0100-3.69
MSFT254.08-12.1200-4.55
XOM90.65-1.4600-1.59
WFC42.11-1.6000-3.66
JNJ175.50-3.3200-1.86
FB192.24-10.3800-5.12
GE75.20-1.2000-1.57
JPM120.09-2.0900-1.71
Earnings HistoryEstimateReportedSurprise %
Q04 2021--0.06-
Q03 2021-0.05-0.0420.00
Q02 2021-0.05-0.06-20.00
Q01 2021-0.06-0.0516.67
Q04 2020-0.07-0.46-557.14
Q03 2020-0.08-0.09-12.50
Q02 2020-0.11-0.12-9.09
Q01 2020-0.36-0.345.56
Earnings Per EndEstimateRevision %Trend
3/2022 QR-0.06-50.00Negative
6/2022 QR-0.05-25.00Negative
12/2022 FY-0.25-31.58Negative
12/2023 FY-0.25-127.27Negative
Next Report Date-
Estimated EPS Next Report-0.06
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume329.58K
Shares Outstanding46.23K
Shares Float116.28M
Trades Count522
Dollar Volume120.53K
Avg. Volume750.18K
Avg. Weekly Volume661.61K
Avg. Monthly Volume527.57K
Avg. Quarterly Volume1.06M

Check-Cap Ltd. (NASDAQ: CHEK) stock closed at 0.363999 per share at the end of the most recent trading day (a 4.45% change compared to the prior day closing price) with a volume of 325.17K shares and market capitalization of 16.87M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 64 people. Check-Cap Ltd. CEO is Alex Ovadia.

The one-year performance of Check-Cap Ltd. stock is -75.41%, while year-to-date (YTD) performance is -46.05%. CHEK stock has a five-year performance of -98.46%. Its 52-week range is between 0.302 and 1.9089, which gives CHEK stock a 52-week price range ratio of 3.92%

Check-Cap Ltd. currently has a PE ratio of -1.70, a price-to-book (PB) ratio of 0.83, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -46.53%, a ROC of -50.41% and a ROE of -52.18%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Check-Cap Ltd., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.06 for the next earnings report. Check-Cap Ltd.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Check-Cap Ltd. is Strong Buy (1), with a target price of $2, which is +447.95% compared to the current price. The earnings rating for Check-Cap Ltd. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Check-Cap Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Check-Cap Ltd. has a Neutral technical analysis rating based on Technical Indicators (ADX : 25.72, ATR14 : 0.03, CCI20 : 10.36, Chaikin Money Flow : 0.19, MACD : -0.01, Money Flow Index : 25.42, ROC : 0.83, RSI : 48.94, STOCH (14,3) : 85.05, STOCH RSI : 1.00, UO : 58.41, Williams %R : -14.95), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Check-Cap Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection.

CEO: Alex Ovadia

Telephone: +972 48303401

Address: 29 Abba Hushi Avenue, Isfiya 3009000, , IL

Number of employees: 64

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

60%40%

Bearish Bullish

65%35%

TipRanks News for CHEK

Mon, 07 Mar 2022 11:25 GMT Analysts Top Healthcare Picks: Check-Cap (CHEK), Axsome Therapeutics (AXSM)

- TipRanks. All rights reserved.

Wed, 05 Jan 2022 09:12 GMT Check-Cap (CHEK) Receives a Hold from Dawson James

- TipRanks. All rights reserved.

News

Stocktwits